• Citer

Gene expression profiling can predict pathological complete response (pCR) to anthracycline-based therapy in estrogen-receptor (ER) negative breast cancer (BC) patients.

par Desmedt, Christine ;Andre, Fabrice;de Azambuja, Evandro ;Haibe-Kains, Benjamin ;Larsimont, Denis ;D'Hondt, Veronique ;Di Leo, Angelo ;Piccart-Gebhart, Martine ;Pusztai, Lajos;Sotiriou, Christos
Référence ASCO Annual Meeting(2007: Chicago, USA), Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings, Vol. Part I. Vol 25, No. 18S, page (abst 10564)
Publication Publié, 2007-06

Publication dans des actes

• Détails

Titre:	Gene expression profiling can predict pathological complete response (pCR) to anthracycline-based therapy in estrogen-receptor (ER) negative breast cancer (BC) patients.
Auteur:	Desmedt, Christine; Andre, Fabrice; de Azambuja, Evandro; Haibe-Kains, Benjamin; Larsimont, Denis; D'Hondt, Veronique; Di Leo, Angelo; Piccart-Gebhart, Martine; Pusztai, Lajos; Sotiriou, Christos
Informations sur la publication:	ASCO Annual Meeting(2007: Chicago, USA), Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings, Vol. Part I. Vol 25, No. 18S, page (abst 10564)
Statut de publication:	Publié, 2007-06
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
	Sciences bio-médicales et agricoles
Langue:	Anglais